Stelling, J.M., Travers, K., Jones, R.N., Turner, P.J., O’Brien, T.F., and Levy, S.B. (2005) Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg. Infect. Dis. 11, 873-82.

Templeton, K.E., Scheltinga, S.A., van den Eeden, W.C.J.F.M., Graffelman, A.W., van den Broek, P.J., and Claas, E.C.J. (2005) Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin. Infect. Dis. 41(3), 345-51.

Thomas, L. (1974) The Lives of a Cell. New York: Viking Press.

Walsh, C. (2003a) Where will new antibiotics come from? Nat. Rev. Microbiol. 1, 65-70.

Walsh, C.T. (2003b) Antibiotics: Actions, Origins, Resistance. Washington, DC: ASM Press.

Walsh, C.T. (2004) Polyketide and nonribosomal peptide antibiotics: modularity and versatility. Science 303, 1805-10.

Williams, P. (2002) Quorum sensing: an emerging target for antibacterial chemotherapy? Expert Opin. Ther. Targets 6, 257-74.

Wilson, M. (2005) Microbial Inhabitants of Humans: Their Ecology and Role in Health and Disease. Cambridge, UK: Cambridge University Press.

Wright, G.D. (2000) Resisting resistance: new chemical strategies for battling superbugs. Chem. Biol. 7, R127-32.

Yang, H., Kim, S.-K., Kim, M., Reche, P.A., Morehead, T.J., Damon, I.K., Welsh, R.M., and Reinherz, E.L. (2005) Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J. Clin. Invest. 115, 379-87.

Yoong, P., Schuch, R., Nelson, D., and Fischetti, V.A. (2004) Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. 186(14), 4808-12.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement